Abbott's MDx Sales Rise 21 Percent in Q2

Abbott's molecular diagnostics sales for the quarter were hit by the negative effects of foreign currency translation but still rose 11 percent.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories